DOCN will need to use this rally to clean up the balance sheet. Short-term dilution is of secondary concern.

I am a long-term DOCN holder. My first buy was around $45 near the IPO period, and I added at roughly $60, $67, $35, $20, and $40. So my view is not from a short-term trader hoping for a quick move. I want DOCN to win over the next 5–10 years.

That is exactly why I think management should seriously consider another common stock offering while the stock price is this elevated.

DOCN still has roughly $1B of debt obligations on the balance sheet, mostly convertible notes. At the same time, the stock has had a major rally and the company is being valued at a rich multiple again.

To me, this is the obvious move:

• Sell approximately $1B of new common stock
• Use the proceeds to repay / retire the remaining debt
• Accept the short-term dilution
• Remove balance sheet pressure
• Let management focus entirely on growth, margin expansion, AI infrastructure, and execution

Yes, the stock could drop 20–30% temporarily after an offering. I would not love that as a shareholder. But as a long-term holder, I would rather own a slightly diluted DOCN with a clean balance sheet than a more leveraged DOCN carrying nearly $1B of debt into an uncertain rate and AI-capex cycle.

This is the kind of market window companies should use. When the market is willing to pay an inflated price for your stock, you should use that equity capital intelligently.

DOCN already raised equity once and used part of it to pay down debt. I think they should finish the job.

A cleaner balance sheet would make DOCN a stronger company, reduce financial risk, improve strategic flexibility, and potentially make the stock more investable for long-term institutions.

My question: why is this NOT the best use of DOCN’s current market rally?